Cytogenomics (India) Private Limited - Company Profile

It is a healthcare private limited company based in Bangalore, Karnataka, India, established in 2004.
2004 Bangalore, Karnataka, India Struck Off
Last Updated:
About Cytogenomics (India) Private Limited

Cytogenomics (India) Private Limited, a struck off private limited company, was established on 23 June 2004 in Bangalore, Karnataka, India. Engaging in other human health activities within the healthcare sector, it holds CIN: U85195KA2004PTC034185. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Pravin Manjeshwar Kini (Director), Sridhar Iyengar Sargur Narashima (Director). Past directors included Srikanth Manchikanti Manchikanti. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at 3004, 12 A Mainhal 2Nd Stage Indiranagar, Bangalore, Karnataka, 560008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85195KA2004PTC034185

  • Registration Number

    034185

  • Incorporation Date

    23 June 2004

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 21 Year, 7 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Cytogenomics (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cytogenomics (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Cytogenomics (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Pravin Manjeshwar Kini Director 23 Jun 2004 Current
Sridhar Iyengar Sargur Narashima Director 05 Apr 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Apr 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cytogenomics (India).

Enhance accessibility to Cytogenomics (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Cytogenomics (India) revenue growth over time
Cytogenomics (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cytogenomics (India)?

Unlock access to Cytogenomics (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cytogenomics (India)?

Unlock and access historical data on people associated with Cytogenomics (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cytogenomics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytogenomics (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cytogenomics (India)
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Cytogenomics (India) Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was documented.

  • Director Appointment

    Sridhar Iyengar Sargur Narashima was appointed as a Director was appointed as a Director on 05 Apr 2013 & has been associated with this company since 12 years 10 months . was recorded as a recent event.

  • Balance Sheet

    Cytogenomics (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Bangalore. was recorded as a recent event.

  • Director Appointment

    Progress on Pravin Manjeshwar Kini was appointed as a Director was appointed as a Director on 23 Jun 2004 & has been associated with this company since 21 years 7 months . was documented.

  • Company Incorporation

    The activity Cytogenomics (India) Private Limited was registered on 23 Jun 2004 with Roc Bangalore & aged 21 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cytogenomics (India) Private Limited?

The CIN of Cytogenomics (India) Private Limited is U85195KA2004PTC034185.

Where is Cytogenomics (India) Private Limited headquartered?

Cytogenomics (India) Private Limited is headquartered at 3004, 12 A Mainhal 2Nd Stage Indiranagar, Bangalore, Karnataka, 560008.

When was Cytogenomics (India) Private Limited incorporated?

Cytogenomics (India) Private Limited was incorporated on 23 June 2004.

Who are the current directors of Cytogenomics (India) Private Limited?

The current directors of Cytogenomics (India) Private Limited are

What is the primary industry of Cytogenomics (India) Private Limited?

The primary industry of Cytogenomics (India) Private Limited is Healthcare.

Is Cytogenomics (India) Private Limited a listed company?

Cytogenomics (India) Private Limited is unlisted.

What is the capital structure of Cytogenomics (India) Private Limited?

The authorized capital of Cytogenomics (India) Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available